Natera, Inc. (NTRA)
Last Price$143.1(8.0%)
Market Cap$18.5B
NTRA Rating
NTRA Quality rating performance
NTRA Intrinsic Value
Key Highlights:
As of Mar 03, 2025 NTRA Relative Value is $73.7, which is overvalued by 48.5%, compared to current share price of $143.1.
As of Mar 03, 2025 NTRA DCF Value is N/A, which is undervalued by N/A, compared to current share price of $143.1.
NTRA Share Price History
1W (9.6%)
1M (18.9%)
6M 25.6%
YTD 131.1%
1Y 58.6%
3Y 138.3%
5Y 291.4%
10Y 695.1%
Share Price
Intrinsic Value
Drawdown
Total Return
vs SP500
vs NASDAQ
Crunching data... Almost there!
NTRA Stock Metrics
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Base
$18.5B
$18.1B
$1,532.0M
($33.2M)
Shares Outstanding
129M
Employees
N/A
Growth (CAGR)
39.9%
16.8%
(0.99%)
(12.8%)
51.7%
(58.51%)
Profitability
57.7%
(15.8%)
(14.0%)
1.6%
(2.2%)
15.5%
Intrinsic Value
$70.9 (50.4% overvalued)
N/A
$70.9
(100.0%)
(15.7%)
Valuation (LTM)
Return on Capital
Financial Health
($446.6M)
13.5x
(19.3x)
54.2%
Dividends
Earnings
May 07, 2025
BEAT by 17.8%
BEAT by (121.0%)
(45.8%)
8 Beat & 2 Miss
NTRA Stock Financials
NTRA Income Statement Metrics
Annual
Quarterly
LTM
NTRA Cash Flow Statement Metrics
Annual
Quarterly
LTM
Operating Cash Flow (OCF)
($247.0M) -42.8% YoY
Capital Expenditure (CAPEX)
($39.2M) -17.8% YoY
Free Cash Flow (FCF)
($286.2M) -40.3% YoY
NTRA Income Statement Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
NTRA Balance Sheet Overview
Annual
Quarterly
LTM
Dec'14
Dec'15
Dec'16
Dec'17
Dec'18
Dec'19
Dec'20
Dec'21
Dec'22
Dec'23
Assets
Liabilities
Total assets
$1,441.7M
Current assets ($1,258.5M, 87.3% of total)
$879.0M (61.0%)
$278.3M (19.3%)
Other current assets
$101.3M (7.0%)
Non-current assets ($183.2M, 12.7% of total)
$0.0 (0.0%)
$167.7M (11.6%)
$0.0 (0.0%)
Other non-current assets
$15.4M (1.1%)
Financial position
($437.0M)
Cash & Short-term
Investments
Total Debt
NTRA Stock Ratios
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
NTRA Earnings Surprises
Crunching data... Almost there!
NTRA Dividends
NTRA Dividend Yield
Crunching data... Almost there!
NTRA Dividend Per Share
3Y
10Y
30Y
Annual
Quarterly
LTM
Competing with NTRA
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Quality rating | Intrinsic value | 1Y Return | Revenue | Free Cash Flow | Revenue growth | FCF margin | Gross margin | ROIC | Total Debt to Equity |
$18.5B | 6.0 | $70.9 50.4% overvalued | 58.6% | $1,532.0M | ($33.2M) | 54.9% | (2.2%) | 57.7% | (44.9%) | 54.2% | |
$201.0B | 6.5 | $602.4 15.0% undervalued | (9.7%) | $42.9B | $7,267.0M | 0.1% | 16.9% | 41.5% | 8.3% | 63.1% | |
$151.3B | 6.1 | $167.0 18.8% overvalued | (19.4%) | $23.9B | $5,296.0M | (0.1%) | 22.2% | 59.5% | 5.9% | 32.3% | |
$36.5B | 7.4 | $103.7 17.9% overvalued | (11.0%) | $6,533.0M | $1,409.0M | (3.0%) | 21.6% | 65.9% | 14.7% | 55.8% | |
$36.1B | 7.2 | $219.3 49.8% overvalued | (23.5%) | $3,897.5M | $798.1M | 6.5% | 20.5% | 61.1% | 49.4% | 6.3% | |
$33.7B | 6.1 | $301.3 63.0% undervalued | (26.5%) | $15.4B | $2,114.0M | 2.5% | 13.7% | 31.4% | 8.8% | 21.7% | |
$27.1B | 7.0 | $869.6 31.5% overvalued | (1.4%) | $3,872.4M | $864.4M | 2.2% | 22.3% | 59.1% | 49.8% | (1,587.1%) | |
$22.2B | 6.5 | $236.1 36.5% overvalued | 7.2% | $2,958.4M | $619.6M | 0.1% | 20.9% | 58.2% | 19.4% | 0.0% | |
$21.2B | 6.1 | $621.0 144.4% undervalued | 17.1% | $13.0B | $1,095.9M | 0.8% | 8.4% | 26.9% | 6.0% | 24.1% | |
$19.6B | 6.0 | $369.8 109.0% undervalued | 44.2% | $9,872.0M | $909.0M | 6.7% | 9.2% | 32.4% | 8.8% | 102.2% | |
$13.9B | 6.2 | $147.2 74.8% undervalued | (37.1%) | $4,372.0M | $696.0M | (2.9%) | 15.9% | 65.4% | 34.6% | 93.8% |
FAQ
What is Natera, Inc. (NTRA) stock rating?
As of today, Natera, Inc. has a stock rating of 6 (out of 10), which is considered Good.
is Natera, Inc. (NTRA) a good stock to buy?
As of today, Natera, Inc. has a Good stock rating, which is 50.4% overvalued. According to Value Sense backtesting, stocks with similar profile tend to underperform the market by 4.6%.